Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
METROPOLIS.NSthis companyMetropolis Healthcare Limited	₹582.35	47.23×	5.93×	5.45×	21.92×	69.1%	47.8%	16.2%	11.5%	12.6%	10.4%	3.3%	0.15×	0.42×	10.88×	1.4×	0.2%	4	—	2	C+
ASPIRA.BOAspira Pathlab & Diagnostics Limited	₹126.95	1,117×	4.68×	2.29×	40.57×	-50.8%	35.3%	-0.3%	0.2%	0.4%	-0.5%	1.9%	0.27×	1.41×	-0.19×	1.43×	0.0%	2	—	1	C-
DLCL.BODr. Lalchandani Labs Ltd.	₹6.47	93.8×	0.43×	1.46×	5.92×	658.4%	59.7%	-11.9%	1.5%	0.4%	-2.0%	-17.9%	0.15×	-3.04×	-28.75×	3.79×	0.0%	3	1.33	2	B-
KRSNAA.NSKrsnaa Diagnostics Limited	₹493.60	16.62×	1.72×	2.18×	8.58×	-320.3%	39.0%	15.7%	13.1%	10.3%	5.9%	-5.6%	0.55×	1.98×	3.53×	2.68×	0.5%	3	—	2	B-
LALPATHLAB.NSDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
NIDAN.NSNidan Laboratories & Healthcare Ltd.	₹13.35	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	68.59×	3.2×	2.24×	17.09×	-23.3%	40.5%	7.7%	7.3%	5.4%	2.7%	-1.9%	0.21×	0.68×	1.67×	3.08×	0.3%	3	1.33	2	—